AKR1B10 and hepatocellular carcinoma: Considering that higher expression of AKR1B10 is correlated with increased survival rate and lower metastatic incidence, AKR1B10 acts as a useful biomarker for the prognosis of HCC (Liu et al., 2015) (Jin et al., 2016).